ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Radiolabeled Herceptin to Increase Treatment Efficacy in Breast Cancer Patients With Low Tumor HER-2/neu Expression
Mapping Intimacies
◽
10.21236/ada430705
◽
2004
◽
Author(s):
David Scheinberg
Keyword(s):
Breast Cancer
◽
Cancer Patients
◽
Treatment Efficacy
◽
Breast Cancer Patients
◽
Her 2
Download Full-text
Related Documents
Cited By
References
Radiolabeled Herceptin to Increase Treatment Efficacy in Breast Cancer Patients With Low Tumor HER-2/neu Expression
10.21236/ada396561
◽
2001
◽
Author(s):
George Sgouros
Keyword(s):
Breast Cancer
◽
Cancer Patients
◽
Treatment Efficacy
◽
Breast Cancer Patients
◽
Her 2
Download Full-text
Radiolabeled Herceptin to Increase Treatment Efficacy in Breast Cancer Patients with Low Tumor HER-2/neu Expression
10.21236/ada408089
◽
2002
◽
Author(s):
George Sgouros
Keyword(s):
Breast Cancer
◽
Cancer Patients
◽
Treatment Efficacy
◽
Breast Cancer Patients
◽
Her 2
Download Full-text
Radiolabeled Herceptin to Increase Treatment Efficacy in Breast Cancer Patients With Low Tumor HER-2/neu Expression
10.21236/ada418347
◽
2003
◽
Author(s):
George Sgouros
Keyword(s):
Breast Cancer
◽
Cancer Patients
◽
Treatment Efficacy
◽
Breast Cancer Patients
◽
Her 2
Download Full-text
Radiolabeled Herceptin to Increase Treatment Efficacy in Breast Cancer Patients with Low Tumor HER-2/neu Expression
10.21236/ada438437
◽
2005
◽
Author(s):
David Scheinberg
◽
George Sgouros
Keyword(s):
Breast Cancer
◽
Cancer Patients
◽
Treatment Efficacy
◽
Breast Cancer Patients
◽
Her 2
Download Full-text
Phase II Study of HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab
10.21236/ada471552
◽
2007
◽
Author(s):
Mary L. Disis
Keyword(s):
Breast Cancer
◽
Cancer Patients
◽
Phase Ii
◽
Phase Ii Study
◽
Stage Iv
◽
Breast Cancer Patients
◽
Her2 Positive
◽
Her 2
◽
Domain Peptide
◽
Positive Breast Cancer
Download Full-text
Phase II Study of a HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab
10.21236/ada533841
◽
2010
◽
Author(s):
Mary L. Disis
Keyword(s):
Breast Cancer
◽
Cancer Patients
◽
Phase Ii
◽
Phase Ii Study
◽
Stage Iv
◽
Breast Cancer Patients
◽
Her2 Positive
◽
Her 2
◽
Domain Peptide
◽
Positive Breast Cancer
Download Full-text
Phase 2 Study of a HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab
10.21236/ada538840
◽
2010
◽
Author(s):
Mary L. Disis
Keyword(s):
Breast Cancer
◽
Cancer Patients
◽
Stage Iv
◽
Phase 2
◽
Breast Cancer Patients
◽
Her2 Positive
◽
Phase 2 Study
◽
Her 2
◽
Domain Peptide
◽
Positive Breast Cancer
Download Full-text
Correlation between ER, PR, HER-2, and Ki-67 with the risk of bone metastases detected by bone scintigraphy in breast cancer patients: A cross sectional study
Annals of Medicine and Surgery
◽
10.1016/j.amsu.2021.102532
◽
2021
◽
pp. 102532
Author(s):
Hanif Afkari
◽
Firdian Makrufardi
◽
Basuki Hidayat
◽
Hendra Budiawan
◽
Achmad Hussein Sundawa Kartamihardja
Keyword(s):
Breast Cancer
◽
Bone Metastases
◽
Cancer Patients
◽
Bone Scintigraphy
◽
Cross Sectional Study
◽
Breast Cancer Patients
◽
Sectional Study
◽
Ki 67
◽
Cross Sectional
◽
Her 2
Download Full-text
Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling
Molecular Genetics & Genomic Medicine
◽
10.1002/mgg3.1079
◽
2019
◽
Vol 8
(2)
◽
Cited By ~ 2
Author(s):
Zhanhong Chen
◽
Tian Sun
◽
Ziyan Yang
◽
Yabing Zheng
◽
Ruoying Yu
◽
...
Keyword(s):
Breast Cancer
◽
Cancer Patients
◽
Treatment Efficacy
◽
Circulating Tumor Dna
◽
Genomic Profiling
◽
Breast Cancer Patients
◽
Monitoring Treatment
◽
Tumor Dna
Download Full-text
Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response
The Breast
◽
10.1016/j.breast.2006.06.008
◽
2007
◽
Vol 16
(1)
◽
pp. 86-93
◽
Cited By ~ 47
Author(s):
A. Rody
◽
T. Karn
◽
R. Gätje
◽
A. Ahr
◽
C. Solbach
◽
...
Keyword(s):
Breast Cancer
◽
Gene Expression
◽
Cancer Patients
◽
Expression Profiling
◽
Topoisomerase Ii
◽
Tumor Response
◽
Breast Cancer Patients
◽
Topoisomerase Ii Alpha
◽
Protein Tau
◽
Her 2
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close